clarithromycin has been researched along with Cardiovascular Diseases in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (12.00) | 29.6817 |
| 2010's | 19 (76.00) | 24.3611 |
| 2020's | 3 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahl, A; Bai, J; Campen, MJ; Chai, H; Chen, C; Chen, J; Chen, X; Cheng, L; Cheng, W; Dong, Q; Easton, J; Engberg, E; Fadladdin, YAJ; Franco, PM; Gao, J; Giri, AR; Goodarzi, Z; Graves, SA; Guo, Y; Holroyd-Leduc, J; Hu, Z; Huang, IC; Hudson, MM; Ji, X; Jiang, J; Johnson, S; Kaur, N; Koivusalo, SB; Kulmala, J; Lan, Q; Leng, S; Li, Q; Li, Y; Li, Z; Liang, R; Liu, F; Liu, Y; Lowman, PE; Ma, X; Menda, Y; Mielke, N; Mulder, H; Neale, G; Ness, KK; Niaz, S; Niu, Q; Pang, H; Park, EA; Plyler, E; Qin, N; Qin, X; Qiu, H; Ren, D; Ren, J; Roach, M; Robison, LL; Roine, RP; Rothman, N; Rottman Pietrzak, KA; Sahrakorpi, N; Sanghavi, DK; Santos, C; Shallom, SJ; Song, N; Spotswood, N; Stach-Lempinen, B; Subota, A; Sun, X; Tammelin, TH; Tang, J; Walker, E; Wang, M; Wang, Z; Xie, J; Xu, J; Xue, J; Xue, M; Yang, S; Yang, Y; Yarrarapu, SNS; Yasui, Y; Yu, H; Yu, W; Zelazny, AM; Zhang, H; Zhang, J; Zhang, X; Zheng, Y; Zhu, D | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
| Chen, PH; Chen, ST; Chen, YY; Khan, N; Lin, CK; Papatheodorou, SI; Park, S; You, CH | 1 |
| Chalmers, JD; Chan, BK; Lang, CC; Mordi, IR; Palmer, CNA; Yanez, ND | 1 |
| Anand, S; Chan, EW; Wong, AYS; Wong, ICK; Worsley, AJ | 1 |
| Hardin, JW; Hyche, S; Magagnoli, J; Sutton, SS | 1 |
| Hviid, A; Inghammar, M; Melbye, M; Nibell, O; Pasternak, B; Svanström, H | 1 |
| Aschenbrenner, DS | 1 |
| Ärnlöv, J; Bring, C; Carlsson, AC; Gluud, C; Hilden, J; Jakobsen, JC; Jensen, GB; Kastrup, J; Kjøller, E; Kolmos, HJ; Larsson, A; Sajadieh, A; Winkel, P; Wuopio, J | 1 |
| Choi, IJ | 1 |
| Ärnlöv, J; Carlsson, AC; Gluud, C; Hilden, J; Jakobsen, JC; Jensen, GB; Kastrup, J; Kjøller, E; Kolmos, HJ; Larsson, A; Nowak, C; Ruge, T; Sajadieh, A; Winkel, P | 1 |
| Hviid, A; Pasternak, B; Svanström, H | 1 |
| Chan, KA; Chang, CH; Chou, HW; Lai, CL; Lai, MS; Wang, JL | 1 |
| Gouya, G; Herkner, H; Mesgarpour, B; Reichardt, B; Wolzt, M | 1 |
| Chan, EW; Chui, CS; Douglas, IJ; Ghebremichael-Weldeselassie, Y; Root, A; Siu, CW; Smeeth, L; Wong, AY; Wong, IC | 1 |
| Alexander, GC; Iyer, G | 2 |
| Blake, Z | 1 |
| Wong, IC | 1 |
| Bhaskaran, K; Brauer, R; Douglas, I; Evans, SJ; Ghebremichael-Weldeselassie, Y; Navaratnam, V; Root, AA; Smeeth, L; Wong, AY; Wong, IC | 1 |
| Bannister, CA; Berni, E; Butler, CC; Currie, CJ; de Voogd, H; Halcox, JP; Jenkins-Jones, S; Jones, B; Ouwens, M | 1 |
| Anderson, GM; Daneman, N; Fischer, HD; Gill, SS; Gruneir, A; Hutson, JR; Rochon, PA; Wang, X | 1 |
| Go, MF | 1 |
| Muhlestein, JB | 1 |
| Ahlberg, J; Asikainen, S; Doğan, B; Mattila, K; Nieminen, MS; Paju, S; Pussinen, PJ; Sinisalo, J; Valtonen, V | 1 |
7 review(s) available for clarithromycin and Cardiovascular Diseases
| Article | Year |
|---|---|
Topics: Adult; Aging; Aluminum; Alzheimer Disease; Animals; Anti-Bacterial Agents; Artemisia annua; Body Mass Index; Brain; Canada; Cancer Survivors; Cardiovascular Diseases; Child; Clarithromycin; Cohort Studies; Cricetinae; Critical Care; Cross-Sectional Studies; Deferoxamine; Dementia; Depression; Diabetes Mellitus, Type 2; Diabetes, Gestational; DNA Methylation; Drug Resistance, Bacterial; Endothelial Cells; Epigenesis, Genetic; Exercise; Female; Ferroptosis; Garlic; Genetic Loci; Genome-Wide Association Study; Humans; Intensive Care Units; Iron; Iron Chelating Agents; Ketamine; Kidney; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Neoplasms; Neuroendocrine Tumors; Neurons; Nigella sativa; Obesity; Overweight; Oxidative Stress; Plant Extracts; Praziquantel; Pregnancy; Quality of Life; Radiometry; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Research Design; Retrospective Studies; RNA, Ribosomal, 23S; Schistosoma mansoni; Schistosomiasis; Schistosomiasis mansoni; Survivors; Vehicle Emissions | 2022 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Clarithromycin use and the risk of mortality and cardiovascular events: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Cause of Death; Clarithromycin; Humans; Myocardial Infarction; Risk Factors | 2019 |
Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Clarithromycin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macrolides; Myocardial Infarction; Observational Studies as Topic; Randomized Controlled Trials as Topic; Risk Factors; Stroke | 2017 |
[
Topics: Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Guidelines as Topic; Helicobacter Infections; Meta-Analysis as Topic; Proportional Hazards Models; Stomach Neoplasms | 2018 |
Treatment and management of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzimidazoles; Cardiovascular Diseases; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Rabeprazole; Stomach Neoplasms; Treatment Outcome | 2002 |
Antibiotic treatment of atherosclerosis.
Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; C-Reactive Protein; Cardiovascular Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Coronary Artery Disease; Coronary Restenosis; Diet, Atherogenic; Fluoroquinolones; Gatifloxacin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Animal; Myocardial Ischemia; Rabbits; Randomized Controlled Trials as Topic; Roxithromycin; Treatment Outcome | 2003 |
3 trial(s) available for clarithromycin and Cardiovascular Diseases
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study.
Topics: Aged; Angina, Unstable; Atherosclerosis; Cardiovascular Diseases; Cathepsin B; Cathepsins; Cerebrovascular Disorders; Clarithromycin; Coronary Disease; Denmark; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Lysosomes; Male; Middle Aged; Mortality; Myocardial Infarction; Peripheral Vascular Diseases; Proportional Hazards Models; Registries; Risk Factors; Treatment Outcome | 2018 |
Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-study.
Topics: Aged; Cardiovascular Diseases; Clarithromycin; Coronary Disease; Endostatins; Female; Humans; Male; Middle Aged; Risk Factors; Single-Blind Method | 2019 |
16 other study(ies) available for clarithromycin and Cardiovascular Diseases
| Article | Year |
|---|---|
Genetic and pharmacological relationship between P-glycoprotein and increased cardiovascular risk associated with clarithromycin prescription: An epidemiological and genomic population-based cohort study in Scotland, UK.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cardiovascular Diseases; Clarithromycin; Cohort Studies; Diabetes Mellitus, Type 2; Female; Genomics; Heart Disease Risk Factors; Humans; Male; Middle Aged; Prescriptions; Scotland; Young Adult | 2020 |
Appraisal of the cardiovascular risks of azithromycin: an observational analysis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cardiovascular Diseases; Clarithromycin; Female; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Retrospective Studies; Risk Factors; Young Adult | 2017 |
Long-Term Risk of Cardiovascular Death With Use of Clarithromycin and Roxithromycin: A Nationwide Cohort Study.
Topics: Age Factors; Aged; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Cohort Studies; Denmark; Female; Humans; Male; Middle Aged; Penicillins; Propensity Score; Retrospective Studies; Roxithromycin; Sex Factors; Time Factors | 2018 |
Antibiotic May Increase CV Risk in those with Heart Disease.
Topics: Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Humans; Risk Factors; United States; United States Food and Drug Administration | 2018 |
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Cohort Studies; Cytochrome P-450 CYP3A Inhibitors; Denmark; Enzyme Inhibitors; Female; Humans; Logistic Models; Male; Middle Aged; Penicillin V; Propensity Score; Registries; Roxithromycin; Sex Factors | 2014 |
Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; beta-Lactamase Inhibitors; Cardiovascular Diseases; Ciprofloxacin; Clarithromycin; Comorbidity; Female; Fluoroquinolones; Humans; Levofloxacin; Logistic Models; Male; Moxifloxacin; Risk; Taiwan | 2015 |
A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death.
Topics: Adult; Aged; Atorvastatin; Cardiovascular Diseases; Clarithromycin; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Dyslipidemias; Female; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Retrospective Studies; Risk; Rosuvastatin Calcium; Simvastatin | 2015 |
Cardiovascular outcomes associated with use of clarithromycin: population based study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Middle Aged; Propensity Score; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 2016 |
Cardiovascular risks associated with clarithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
Study provides insufficient evidence of a link between clarithromycin and myocardial infarction.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
Editorialists' reply to Blake.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
Author's reply to Blake.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cardiovascular Diseases; Case-Control Studies; Child; Child, Preschool; Clarithromycin; Cohort Studies; Databases, Factual; Female; Helicobacter Infections; Humans; Infant; Male; Middle Aged; Myocardial Infarction; Propensity Score; United Kingdom; Young Adult | 2016 |
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Cause of Death; Clarithromycin; Doxycycline; Erythromycin; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Risk Factors; United Kingdom | 2017 |
Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Atrioventricular Block; Bradycardia; Cardiovascular Diseases; Case-Control Studies; Cholinesterase Inhibitors; Clarithromycin; Cohort Studies; Cytochrome P-450 CYP3A Inhibitors; Donepezil; Drug Interactions; Drug Prescriptions; Enzyme Inhibitors; Female; Humans; Indans; Macrolides; Male; Ontario; Piperidines; Syncope | 2012 |
Clarithromycin reduces recurrent cardiovascular events in subjects without periodontitis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aggregatibacter actinomycetemcomitans; Cardiovascular Diseases; Clarithromycin; Endpoint Determination; Female; Finland; Humans; Immunoglobulin G; Lipopolysaccharides; Male; Middle Aged; Periodontitis; Porphyromonas gingivalis; Regression Analysis; Secondary Prevention; Statistics, Nonparametric | 2006 |